HUMIRA 20mg for S.C. Injection Syringe 0.2mL (ヒュミラ皮下注20mgシリンジ0.2mL)

Țară: Japonia

Limbă: engleză

Sursă: すりの適正使用協議会 RAD-AR Council, Japan

Ingredient activ:

Adalimumab(genetical recombination)

Disponibil de la:

AbbVie GK

INN (nume internaţional):

Adalimumab(genetical recombination)

Forma farmaceutică:

colorless, limpid or slightly opalescent injectable solution in prefilled syringe

Prospect

Drug Information Sheet("Kusuri-no-Shiori")
Self-injection
Revised: 09/2021
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
HUMIRA 20MG FOR S.C. INJECTION SYRINGE
0.2ML
ACTIVE INGREDIENT:
Adalimumab(genetical recombination)
DOSAGE FORM:
colorless, limpid or slightly opalescent injectable solution in
prefilled syringe
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine suppresses function of TNF-α, which is one of the
possible primary causative
substances in juvenile idiopathic arthritis and ulcerative colitis.
TNF (tumor necrosis factor) is
one of the cytokines existing inside of the body even in a healthy
state, and involved in
activities of immunity and development of inflammation or pain.
It is usually used to treat diseases described below with inadequate
response to conventional
therapies: active, polyarticular-course juvenile idiopathic arthritis;
and moderate or severe
ulcerative colitis (children).
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itching,
rash, etc.) to any
medicines or foods.
・If you have or are suspected of having infections such as sepsis.
・If you have or have a history of tuberculosis or hematologic
disease.
・If you have or have a past medical or family history of
demyelinating diseases such as
multiple sclerosis.
・If you are a hepatitis B virus carrier or have a history of
hepatitis B virus infection.
・If you have just received live vaccine.
・If you have congestive heart failure.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (So